Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where P. Maciel is active.

Publication


Featured researches published by P. Maciel.


Neurology | 1996

Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients

Isabel Silveira; I. Lopes-Cendes; Stephen J. Kish; P. Maciel; Claudia Gaspar; Paula Coutinho; M. I. Botez; H. Teive; W. Arruda; C. E. Steiner; W. Pinto-Junior; J. A. Maciel; S. Jain; G. Sack; Eva Andermann; Lewis Sudarsky; Roger N. Rosenberg; Patrick MacLeod; David Chitayat; Riyana Babul; Jorge Sequeiros; Guy A. Rouleau

Article abstract-The spinocerebellar ataxias (SCAs) are a heterogeneous group of neurodegenerative disorders varying in both clinical manifestations and mode of inheritance. Six different genes causing autosomal dominant SCA are mapped: SCA1, SCA2, Machado-Joseph disease (MJD)/SCA3, SCA4, SCA5, and dentatorubropallidoluysian atrophy (DRPLA). Expansions of an unstable trinucleotide CAG repeat cause three of these disorders: SCA type 1 (SCA1), MJD, and DRPLA. We determined the frequency of the SCA1, DRPLA, and MJD mutations in a large group of unrelated SCA patients with various patterns of inheritance and different ethnic backgrounds. We studied 92 unrelated SCA patients. The frequency of the SCA1 mutation was 3% in the overall patient group and 10% in the non-Portuguese dominantly inherited SCA subgroup. We found the DRPLA mutation in only one Japanese patient, who was previously diagnosed with this disease. We identified the MJD mutation in 41% of the overall patient group, which included 38 autosomal dominant kindreds of Portuguese origin; the frequency of the MJD mutation among the non-Portuguese dominantly inherited cases was 17%. These results suggest that SCA may be occasionally caused by the SCA1 mutation and rarely caused by the DRPLA mutation and that, to date, the MJD mutation seems to be the most common cause of dominantly inherited SCA. Finally, our results suggest that recessively inherited cases of SCA are not caused by the known trinucleotide repeat expansions. NEUROLOGY 1996;46: 214-218


Neurology | 2005

Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement.

P. Maciel; Vítor Tedim Cruz; Marco Constante; I. Iniesta; Maria do Carmo Costa; S. Gallati; Nuno Sousa; Jorge Sequeiros; Paula Coutinho; Manuela Santos

The authors identified a missense mutation in the FTL gene (474G>A; A96T) in a 19-year-old man with parkinsonism, ataxia, corticospinal signs, mild nonprogressive cognitive deficit, and episodic psychosis. This mutation was also present in his asymptomatic mother and younger brother, who had abnormally low levels of ferritin in the serum. The patient and his mother displayed bilateral involvement of the pallidum.


Pediatric Neurology | 2003

Inherited and acquired risk factors and their combined effects in pediatric stroke

Sameiro Barreirinho; Anabela Ferro; Manuela Santos; E.lísio Costa; Jorge Pinto-Basto; Alda Sousa; Jorge Sequeiros; P. Maciel; Clara Barbot; José Barbot

The aim of this study was to identify hereditary and acquired risk-factors as they are related to the occurrence of stroke in children. We identified 21 children with stroke. A search of the Factor V Leiden mutation, the Factor II G20210A variant, and the thermolabile variant of methylenetetrahydrofolate reductase was performed in patients and in a control group (n = 115). We identified risk factors of acquired and/or hereditary nature for stroke in 19 of 21 children. Eleven children had three or more risk factors, seven had two risk factors, and one child had only one risk factor. We found three carriers (14.3%) of the Factor V Leiden mutation, two carriers (9.5%) of the Factor II G20210A variant, eleven (52.4%) thermolabile variant of methylenetetrahydrofolate reductase heterozygote carriers, and one (4.8%) homozygotes for this variant. Frequencies of the Factor V Leiden mutation and the Factor II variant were higher in patients than in controls, suggesting that these variants are associated with an increased risk of stroke in childhood. Homozygosity for the thermolabile variant of methylenetetrahydrofolate reductase was equally frequent amongst patients and controls. Our study confirms that stroke in children is commonly associated with a combination of multiple risk factors, both genetic and acquired, and that the Factor V Leiden mutation and the Factor II G20210A variant are predisposing factors for this situation.


American Journal of Medical Genetics | 1998

Analysis of SCA1, DRPLA, MJD, SCA2, and SCA6 CAG repeats in 48 portuguese ataxia families

Isabel Silveira; Paula Coutinho; P. Maciel; Claudia Gaspar; Hayes S; Dias A; João Guimarães; Leal Loureiro; Jorge Sequeiros; Guy A. Rouleau

The spinocerebellar ataxias (SCAs) are clinically and genetically a heterogeneous group of neurodegenerative disorders. To date, eight different loci causing SCA have been identified: SCA1, SCA2, Machado-Joseph disease (MJD)/SCA3, SCA4, SCA5, SCA6, SCA7, and dentatorubropallidoluysian atrophy (DRPLA). Expansion of a CAG repeat in the disease genes has been found in five of these disorders. To estimate the relative frequencies of the SCA1, DRPLA, MJD, SCA2, and SCA6 mutations among Portuguese ataxia patients, we collected DNA samples from 48 ataxia families and performed polymerase chain reaction (PCR) amplification of the CAG repeat mutations on chromosomes 6p, 12p, 14q, 12q, and 19p, respectively. Fifty-five individuals belonging to 34 dominant families (74%) had an expanded CAG repeat at the MJD gene. In five individuals from two kindreds with a dominant pattern of inheritance (4%), an expanded CAG repeat at the SCA2 gene was found. In MJD patients, the normal allele size ranged from 13 to 41, whereas the mutant alleles contained 65 to 80 repeats. For the SCA2 patients, normal alleles had 22 or 23, while expanded alleles had between 36 and 47 CAG units. We did not find the SCA1, DRPLA, or SCA6 mutations in our group of families. The MJD mutation remains the most common cause of SCA in Portugal, while a small number of cases are caused by mutations at the SCA2 gene, and 22% are due to still unidentified genes.


Journal of Human Genetics | 2001

The genomic structure and expression of MJD, the Machado-Joseph disease gene

Yaeko Ichikawa; Jun Goto; Masahira Hattori; Atsushi Toyoda; K. Ishii; Seon-Yong Jeong; Hideji Hashida; Naoki Masuda; Katsuhisa Ogata; Fumio Kasai; Momoki Hirai; P. Maciel; Guy A. Rouleau; Yoshiyuki Sakaki; Ichiro Kanazawa

AbstractMachado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disorder that is clinically characterized by cerebellar ataxia and various associated symptoms. The disease is caused by an unstable expansion of the CAG repeat in the MJD gene. This gene is mapped to chromosome 14q32.1. To determine its genomic structure, we constructed a contig composed of six cosmid clones and eight bacterial artificial chromosome (BAC) clones. It spans approximately 300kb and includes MJD. We also determined the complete sequence (175,330bp) of B445M7, a human BAC clone that contains MJD. The MJD gene was found to span 48,240bp and to contain 11 exons. Northern blot analysis showed that MJD mRNA is ubiquitously expressed in human tissues, and in at least four different sizes; namely, 1.4, 1.8, 4.5, and 7.5kb. These different mRNA species probably result from differential splicing and polyadenylation, as shown by sequences of the 21 independent cDNA clones isolated after the screening of four human cDNA libraries prepared from whole brain, caudate, retina, and testis. The sequences of these latter clones relative to the MJD gene in B445M7 indicate that there are three alternative splicing sites and eight polyadenylation signals in MJD that are used to generate the differently sized transcripts.


Annals of Neurology | 2003

Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients

Mehdi Alizadeh; Marie Claude Babron; Brigitte Birebent; Fumihiko Matsuda; Erwann Quelvennec; Roland S. Liblau; Isabelle Cournu-Rebeix; Patricia Momigliano-Richiardi; Jorge Sequeiros; Jacqueline Yaouanq; Emmanuelle Génin; Alexandre Vasilescu; Héloise Bougerie; Maria Trojano; Berta Martins Silva; P. Maciel; Françoise Clerget-Darpoux; Michel Clanet; Gilles Edan; Bertrand Fontaine; Gilbert Semana

Multiple sclerosis is a chronic inflammatory disease of the central nervous system with a genetic component. Until now, the more consistent association with the disease is found with the major histocompatibility complex, especially HLA‐DRB1*1501‐DQB1*0602 haplotype. In this report, we demonstrate the interaction of Cytotoxic T Lymphocyte‐associated antigen 4 (CTLA‐4 [CD152]) gene with DRB1*15 haplotype in multiple sclerosis genetic susceptibility. Our data were obtained from two European independent family‐based studies including 610 multiple sclerosis family trios. Ann Neurol 2003;54:119–122


Brain & Development | 2009

Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment

Teresa Temudo; M. Rios; C. Prior; Inês Carrilho; Manuela Santos; P. Maciel; Jorge Sequeiros; Maria José Fonseca; José Paulo Monteiro; Pedro Cabral; José Pedro Vieira; Aida Ormazabal; Rafael Artuch

BACKGROUNDnRett disorder (RD) is a progressive neurodevelopmental entity caused by mutations in the MECP2 gene. It has been postulated that there are alterations in the levels of certain neurotransmitters and folate in the pathogenesis of this disease. Here we re-evaluated this hypothesis.nnnPATIENTS AND METHODSnWe evaluated CSF folate, biogenic amines and pterines in 25 RD patients. Treatment with oral folinic acid was started in those cases with low folate. Patients were clinically evaluated and videotaped up to 6 months after therapy.nnnRESULTSnCSF folate was below the reference values in 32% of the patients. Six months after treatment no clinical improvement was observed. Three of the four patients with the R294X mutation had increased levels of a dopamine metabolite associated to a particular phenotype. Three patients had low levels of a serotonin metabolite. Two of them were treated with fluoxetine and one showed clinical improvement. No association was observed between CSF folate and these metabolites, after adjusting for the patients age and neopterin levels.nnnCONCLUSIONnOur results support that folinic acid supplementation has no significant effects on the course of the disease. We report discrete and novel neurotransmitter abnormalities that may contribute to the pathogenesis of RD highlighting the need for further studies on CSF neurotransmitters in clinically and genetically well characterized patients.


Neurology | 2007

Stereotypies in Rett syndrome Analysis of 83 patients with and without detected MECP2 mutations

Teresa Temudo; Pedro Oliveira; Mónica Santos; Karin Dias; José Pedro Vieira; Ana Moreira; Eulália Calado; Inês Carrilho; Guiomar Oliveira; António Levy; Clara Barbot; Maria José Fonseca; Alexandra Cabral; Ana I. Dias; Pedro Cabral; José Paulo Monteiro; Luís Borges; Roseli Gomes; C. Barbosa; G. Mira; F. Eusébio; Jorge Sequeiros; P. Maciel

Background: Hand stereotypies are considered a hallmark of Rett syndrome (RTT) and are usually described as symmetric movements at the midline. However, related pathologies may show the same type of involuntary movement. Furthermore, patients with RTT also have stereotypies with other localizations that are less well characterized. Methods: We analyzed stereotypies in 83 patients with RTT, 53 with and 30 without a mutation detected in the MECP2 gene. Patients were observed and videotaped always by the same pediatric neurologist. Stereotypies were classified, and data were submitted to statistical analysis for comparison of mutation-positive and -negative patients and analysis of their evolution with the disease. Results: All the patients showed hand stereotypies that coincided with or preceded the loss of purposeful hand movements in 62% of the patients with MECP2 mutations.The hair pulling stereotypy was more frequent in the group with detected mutations, whereas hand washing was not. Hand gaze was absent in all RTT patients with MECP2 mutations. Patients with MECP2 mutations also had more varied stereotypies, and the number of stereotypies displayed by each patient decreased significantly with age in this group. In all patients, stereotypies other than manual tended to disappear with the evolution of the disease. Conclusions: Although symmetric midline hand stereotypies were not specific to patients with an MECP2 mutation, some of the other stereotypies seemed to be more characteristic of this group. In patients younger than 10 years and meeting the necessary diagnostic criteria of Rett syndrome, the association of hand stereotypies without hand gaze, bruxism, and two or more of the other stereotypies seemed to be highly indicative of the presence of an MECP2 mutation.


Multiple Sclerosis Journal | 2004

Genotypes at the APOE and SCA2 loci do not predict the course of multiple sclerosis in patients of Portuguese origin

Mónica Santos; Maria do Carmo Costa; Maria Edite Rio; Maria José Sá; Marta Monteiro; Angela Valença; Alfredo Sá; José Dinis; José Figueiredo; Luís Almeida; António Valongueiro; Isabel Coelho; Maria Teresa Matamá; Jorge Pinto-Basto; Jorge Sequeiros; P. Maciel

Multiple sclerosis (MS) is a demyelinating disease that affects about one in 500 young Europeans. In order to test the previously proposed influence of the A PO E and SC A 2 loci on susceptibility to MS, we studied these loci in 243 Portuguese patients and 192 healthy controls and both parents of 92 patients. We did not detect any significant difference when A PO E and SC A 2 allele frequencies of cases and controls were compared, or when we compared cases with different forms of the disease. Disequilibrium of transmission was tested for both loci in the 92 trios, and we did not observe segregation distortion. To test the influence of the A PO E o4 and SC A 2 22 C AGs alleles on severity of disease, we compared age at onset and progression rate between groups with and without those alleles. We did not observe an association of the o4 or the 22 C AG s alleles with rate of progression in our total patient population; allele o4 was associated with increased rate of progression of MS in a subset of patients with less than 10 years of the disease. However, globally in the Portuguese population, the A PO E and SC A2 genes do not seem to be useful in the clinical context as prognostic markers of this disorder.


Human Heredity | 2005

Population Genetics of Wild-Type CAG Repeats in the Machado-Joseph Disease Gene in Portugal

Manuela Lima; Maria do Carmo Costa; Rafael Montiel; Anabela Ferro; Cristina Santos; Catarina Silva; Conceição Bettencourt; Alda Sousa; Jorge Sequeiros; Paula Coutinho; P. Maciel

Objective: To gain insights on the molecular mechanisms of mutation that led to the emergence of expanded alleles in the MJD gene, by studying the behavior of wild-type alleles and testing the association of its distribution with the representation of the disease. Methods: The number of CAG motifs in the MJD gene was determined in a representative sample of 1000 unrelated individuals. Associations between the repeat size and the epidemiological representation of MJD were tested. Results: The allelic profile of the total sample was in the normal range (13–41 repeats), with mode (CAG)23. No intermediate alleles were present. Allelic size distribution showed a negative skew. The correlation between the epidemiological representation of MJD in each district and the frequency of small, medium and large normal alleles was not significant. Further correlations performed grouping the districts also failed to produce significant results. Conclusions: The absence of association between the size of the repeats and the representation of MJD demonstrates that prevalence is not an indirect reflection of the frequency of large normal alleles. Globally the results obtained are in accordance with a model that postulates the occurrence of a few mutations on the basis of most of the MJD cases worldwide.

Collaboration


Dive into the P. Maciel's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Claudia Gaspar

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Manuela Santos

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar

Alda Sousa

Instituto de Biologia Molecular e Celular

View shared research outputs
Researchain Logo
Decentralizing Knowledge